Results 81 to 90 of about 327,270 (275)
Background: Thymoma is a key risk factor for myasthenia gravis (MG). The purpose of our study was to investigate the potential key genes responsible for MG patients with thymoma.
Hui Liu +4 more
doaj +1 more source
Computed Tomography differential features of Anterior Mediastinal Thymoma and Lymphoma
Background: To identify the CT features of anterior mediastinal thymoma and lymphoma and evaluate CT findings that may help in suggesting specific diagnosis among these tumors.
Sagar Thapa +5 more
doaj +1 more source
Extensive primary malignant thymoma involving pericardium, pleura, diaphragm and lungs--a case report [PDF]
Malignant thymoma is an extremely rare entity. According to a study, the annual incidence of malignant thymoma was estimated to be 0.15 per 100,000 person-years. We present the case of a 42-year-old female who came to us with a Type AB, Masaoka stage III
Fatimi, Saulat H +4 more
core +1 more source
Mediastinal neoplasms in patients with Graves disease: a possible link between sustained hyperthyroidism and thymic neoplasia? [PDF]
Background Anterior mediastinal masses are a rare but well documented finding in Graves disease. The vast majority of these lesions represents benign thymic hypertrophy and regress after treatment of the hyperthyroidism.
Boyd, Jonathan D, Juskevicius, Ridas
core +2 more sources
High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression
The first discovery of miR5700 in tumour progression: 1. Atypical type A thymoma was the most invasive and metastatic subtype of thymic epithelial tumour, and difficult to diagnose in pathology owing to the scarcity of specific biomarkers and well‐defined molecular targets. 2. miR‐5700 was markedly overexpressed in atypical type A thymoma. 3.
Li Zhao +4 more
wiley +1 more source
Efficacy of rituximab in thymoma associated minimal change disease: case report
Background Thymomas have been associated with a broad spectrum of autoimmune diseases. Minimal change disease (MCD) is the most frequent pathological lesion reported. Pathophysiological mechanisms involved in secondary MCD, and linking MCD to thymoma are
Zhour El Ouafi +6 more
doaj +1 more source
Thymomatous myasthenia gravis [PDF]
BACKGROUND: Myasthenia gravis (MG) is an autoimmune disorder targeting skeletal muscle acetylcholine receptor. Thymoma is associated with MG in some patients, the majority of whom present with symptoms of MG before detection of underlying thymoma.
Chan, KH +9 more
core
Beyond bacterial defences: the role of lysozyme in cancer
Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang +4 more
wiley +1 more source
Absence of an embryonic stem cell DNA methylation signature in human cancer. [PDF]
BackgroundDifferentiated cells that arise from stem cells in early development contain DNA methylation features that provide a memory trace of their fetal cell origin (FCO). The FCO signature was developed to estimate the proportion of cells in a mixture
Christensen, Brock C +5 more
core
Case Report and Literature Review: Intrathyroid Thymic Carcinoma
This case report highlights the challenges in diagnosing intrathyroid thymic carcinoma (ITTC), a rare thyroid tumor, and underscores the importance of postoperative pathology for confirmation. The study emphasizes the good prognosis of ITTC with appropriate surgical management.
Jia‐Yue Sun +3 more
wiley +1 more source

